found that berberine ameliorated fatty acid oxidation and related metabolic disorders in podocytes of diabetic kidney disease (DKD) mice by promoting PGC-1α to regulate mitochondrial energy homeostasis (69). This evidence concerns the gene PPARGC1A and diabetic kidney disease.